DHS WisdomTree U.S. High Dividend Fund

Expense Ratio
0.38%
Dividend
3.25%
Previous close
$114.00
Est. 12 months change
+13.80%
Projected Price
$129.74

Profitability Metrics

Return on Equity (ROE)
18.40%
Return on Assets (ROA)
7.84%
Return on Invested Capital (ROIC)
13.97%
Weighted Average Cost of Capital (WACC)
6.26%
ROIC - WACC
7.71%
Updated : 2026-09-26 06:37 ET

Valuation Metrics

P/E Ratio
17.34
Forward P/E
12.59
PEG Ratio
3.21
Debt Current Ratio
1.59

Growth & Cash Flow

Gross Margin
54.27%
Operating Margin
27.46%
FCF Margin
22.25%
TTM Revenue Growth
13.93%
Projected 12M EPS Growth
37.75%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
ABBV5.19%
MRK4.96%
XOM3.66%
MO3.61%
PM3.27%
T3.19%
TXN3.11%
VZ2.75%
CVX2.71%
BMY2.52%

ETF Analysis

Fund Overview

WisdomTree U.S. High Dividend Fund (DHS) currently reports 314 stock positions (subject to change), placing it in the widely diversified range by holdings breadth. The top line-up is ABBV (5.19%), MRK (4.96%), XOM (3.66%), with ABBV as the largest single weight at 5.19%. Together, the top three holdings account for 13.81%, which suggests a more balanced distribution of weight across the portfolio, reducing single-name sensitivity at the top. Taken together, the portfolio's structure reflects a deliberate trade-off between conviction at the top and risk spreading across the broader holding set.

Profitability & Capital Efficiency

On a capital return basis, ROIC is 13.97%, WACC is 6.26%, and the economic spread is 7.71%. On balance, the economic spread is positive but compressed — adequate for value preservation, less convincing for aggressive compounding. Supporting metrics show ROE at 18.40% and ROA at 7.84%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio that is value-creative but with less room for execution slippage.

Valuation

On valuation, the portfolio registers trailing P/E of 17.34, forward P/E of 12.59, PEG of 3.21. The minimal trailing-to-forward compression implies limited earnings growth expectations are embedded in current prices. The PEG ratio is elevated relative to historical norms, implying the market is paying a meaningful premium for the earnings trajectory embedded in analyst estimates. A current ratio of 1.59 suggests the holdings have sufficient short-term liquidity without excess. Taken together, the multiple and liquidity picture suggests a portfolio that is priced for a constructive outcome — but where execution against earnings estimates will be the key determinant of whether that price is justified.

Margins & Cash Generation

Stripping to unit economics, gross margin sits at 54.27%, operating margin at 27.46%, and free cash flow margin at 22.25%. Gross margins are healthy, suggesting solid pricing power across the underlying holdings. The operating margin reading is constructive, suggesting management teams are managing overhead costs effectively. At this FCF margin level, the underlying holdings demonstrate good cash generation relative to the revenue base. Together, these margin readings describe a portfolio of businesses that protect profitability at every layer of the income statement.

Growth & Forward Outlook

Connecting operational trends with market expectations, TTM revenue growth of 13.93% indicating steady top-line growth at the portfolio level, while the estimated 12-month price change of 13.94%, where consensus targets suggest reasonable upside rather than a step-change rerating. At 37.8%, the projected 12-month EPS growth rate is strong enough to be a primary driver of the forward investment case rather than a peripheral supporting detail. Operating momentum and analyst expectations are related but distinct — the former is backward-looking by nature, the latter inherently speculative. Against that backdrop, the more durable question is whether operating trends can be sustained long enough for analyst expectations to be validated. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

Overall, the fundamentals support a constructive stance — execution remains the key driver of whether the forward case is fully validated.

This assessment reflects quantitative metrics only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.